An interventional study of CTP scan and Neurological and neuropsychological testing in Aneurysmal Subarachnoid Hemorrhage and Cerebral Ischemia, sponsored by Stanford University. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-06-26.
Sponsored by Stanford University · Not applicable, Interventional, and Diagnostic
Aneurysmal subarachnoid hemorrhage (aSAH) is a significant public health concern, annually affecting over 30,000 Americans and ranking among the leading causes of stroke-related life-years lost in individuals aged 65 and younger. Delayed cerebral ischemia (DCI), occurring in 20% to 40% of aSAH survivors, is a major contributor to brain injury and disability. Timely recognition of DCI is crucial for improving neurological outcomes and preventing irreversible cerebral infarction. However, current methods have substantial limitations, hindering early and reliable detection. This proposal seeks to address these challenges through determining the ability of perfusion imaging to predict DCI and correlate with neurological and neuropsychological outcomes.
Patients with a diagnosis of aSAH and no early radiologic vasospasm on admission demonstrated by DSA will receive a CT Perfusion (CTP) scan within 48 hours of aSAH symptom onset. The researchers seek to determine whether these baseline scans will identify perfusion parameters predictive of DCI. At 12-months mark post-hemorrhage, neurological and neuropsychological tests will be conducted to determine whether perfusion imaging correlates with neurological and neuropsychological outcomes.
Exclusion Criteria:
Patients will undergo the following study procedures: * a CTP scan after aSAH diagnosis * neurological and the neuropsychological tests at 12-month after the hemorrhage.
Radiation: CTP scan · Diagnostic Test: Neurological and neuropsychological testing
Patients with diagnosed aSAH and no evidence of early radiologic vasospasm will receive a CTP scan within 48 hours of aSAH symptom onset.
All enrolled patients will receive neurological and neuropsychological assessment at 12 months after aSAH.
Occurrence of Delayed Cerebral Ischemia (DCI)
DCI will be diagnosed using the 2010 consensus definition, including new focal neurological impairments (e.g., hemiparesis, aphasia, apraxia, hemianopia, or neglect) or a decrease of ≥2 points on the Glasgow Coma Scale lasting ≥1 hour, not immediately after aneurysm treatment and not due to other identifiable causes.
Time frame: During hospitalization (within 14 days of aneurysmal subarachnoid hemorrhage (aSAH))
Correlation Between Baseline Perfusion Parameters and 12-Month Neurological Outcome
Assessment of whether poor baseline perfusion profile (DCI Index Score (DIS) \> 0.06) correlates with worse outcomes on neurological and neuropsychological assessments including modified Rankin Scale (mRS), 36-Item Short Form Health Survey (SF-36), and standardized cognitive test z-scores.
Time frame: 12 months post-aSAH
Modified Rankin Scale (mRS)
Measurement of functional disability using mRS, categorized as favorable (0-3) or unfavorable (4-6), to assess long-term disability and its association with baseline perfusion.
Time frame: 12 months post-aSAH
Health-Related Quality of Life (HRQoL, SF-36)
HRQoL will be reported as standardized z-scores, with higher scores indicating better performance.
Time frame: 12 months post-aSAH
Global Mental Status - Montreal Cognitive Assessment (MoCA)
Screens for mild cognitive impairment across multiple cognitive domains. Raw scores range from 0 to 30. Favorable outcome: MoCA score ≥ 26, unfavorable outcome: MoCA score \< 26 (suggestive of cognitive impairment).
Time frame: 12 months post-aSAH
Executive Functioning - Wisconsin Card Sorting Test (WCST)
Measures executive functioning, including cognitive flexibility and problem-solving. The number of categories completed and total errors will be converted to age-adjusted z-scores. Favorable outcome: z-score ≥ -1.0, unfavorable outcome: z-score \< -1.0 (indicative of cognitive impairment in executive functioning).
Time frame: 12 months post-aSAH
Processing Speed - Symbol Digit Modalities Test (SDMT)
Assesses visual scanning, tracking, and motor speed. Raw scores are adjusted for age and converted to z-scores. Favorable outcome: z-score ≥ -1.0, unfavorable outcome: z-score \< -1.0
Time frame: 12 months post-aSAH
Language - Boston Naming Test (BNT)
Evaluates confrontational word retrieval and naming ability. Scores are standardized using age norms. Favorable outcome: z-score ≥ -1.0, unfavorable outcome: z-score \< -1.0
Time frame: 12 months post-aSAH
Verbal Fluency - FAS Test
Tests lexical fluency by asking participants to generate words beginning with F, A, and S in a set time period. Z-scores are calculated from age-adjusted norms. Favorable outcome: z-score ≥ -1.0, unfavorable outcome: z-score \< -1.0
Time frame: 12 months post-aSAH
Memory - Hopkins Verbal Learning Test-Revised (HVLT-R)
Assesses verbal learning and memory, including immediate recall, delayed recall, and recognition. Performance is normed and converted into z-scores. Favorable outcome: z-score ≥ -1.0, unfavorable outcome: z-score \< -1.0
Time frame: 12 months post-aSAH
Composite Neuropsychological Test Scores
Analysis of cognitive function via composite z-scores derived from tests across executive function, memory, language, verbal fluency, processing speed, and global cognition (e.g., MoCA, HVLT-R, Boston Naming Test). Worse outcomes are defined by lower neuropsychological z-scores.
Time frame: 12 months post-aSAH
No study locations are listed for this record.
Plan to share: No
This study is not yet recruiting, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Stanford University